Fairmount Funds Management’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-29,676
Closed -$4.13M 15
2019
Q4
$4.13M Buy
+29,676
New +$4.13M 2.5% 11